
The phrase well-woman visit refers to care focused on prevention. HealthCare.gov includes it among services that give women a chance to receive recommended screening and other preventive care. MedlinePlus describes a checkup as a place for a physical exam, screening tests, vaccines and counseling. Which parts are relevant can depend on the person's age, health and family history. A question about what will happen during the visit and a question about which test is due can have different answers.
Discussion, exams and screening
Routine care may include a conversation about health history or concerns before the physical exam. MedlinePlus lists family health history, questions and a list of medicines as information that can help shape the discussion. It also describes counseling about ordinary concerns such as activity and habits. A mental list of issues and a written record can provide different kinds of detail. The page on health records, visits and coverage describes the kinds of records a patient can review later, such as a visit note or test result.
The American College of Obstetricians and Gynecologists distinguishes the general exam from the pelvic exam, which includes an external look at the vulva and two internal checks. The general exam can include blood pressure, height and weight. The external exam is a look at the vulva, the tissue outside the vaginal opening. In an internal exam, an instrument called a speculum allows the clinician to see the vagina and cervix. Another part of the pelvic exam can involve feeling the organs of the pelvis, the area below the abdomen. The National Cancer Institute describes cervical screening tests that use a sample of cells. A pelvic exam and a screening test therefore describe different parts of care.
Screening looks for a condition before it produces signs or symptoms. The National Cancer Institute uses breast cancer screening to explain the distinction and describes additional testing that may follow an unusual finding. An abnormal screening result can occur in someone who does not have cancer. A screening test can also miss a cancer. These are reasons that a screening result and a diagnosis have different meanings.
A first gynecologic visit
The American College of Obstetricians and Gynecologists recommends a first gynecologic visit between ages 13 and 15. Its FAQ explains that the visit may simply be a conversation about the body, periods and growing up. There may also be a general exam or vaccination. It describes discussion of confidentiality as part of the visit. It distinguishes a first visit from a pelvic exam, which usually is unnecessary at that visit unless a concern such as pain or unusual bleeding needs evaluation.
The ACOG committee opinion The Initial Reproductive Health Visit: ACOG Committee Opinion, Number 811 (2020) describes the initial visit as a chance for preventive care, education and attention to particular concerns. The opinion says the visit's scope can depend on the patient's development, health history and care already received from other professionals. It describes the value of having time to speak privately with a health care professional and notes that confidentiality requirements vary.
Screening recommendations and what the tests measure
The U.S. Preventive Services Task Force recommends screening mammography for the population specified in its breast cancer recommendation. The recommendation covers cisgender women and other people assigned female at birth in the age group, including people with dense breasts or a close family history of breast cancer. It excludes people with a known high-risk genetic syndrome, previous breast cancer or certain other histories described by the Task Force. The National Cancer Institute defines a mammogram as an X-ray image of the breast. The National Cancer Institute describes mammography as the standard screening test for most women and describes a clinical breast exam as a physical examination that does not serve as an adequate screening test on its own. The Task Force says evidence is insufficient to assess the balance of benefits and harms of screening mammography in women 75 years or older. It makes a separate statement about the lack of sufficient evidence for adding ultrasound or MRI after a negative screening mammogram in women with dense breasts.
The word cytology in the cervical recommendation means looking for cell changes. Pap and HPV tests take samples from the cervix, the lower opening of the uterus. The National Cancer Institute describes the Pap test as checking for cell changes and the HPV test as looking for types of human papillomavirus associated with cervical cancer. Cotesting means doing both kinds of screening together. The Task Force distinguishes routine screening from follow-up after high-grade precancer or cervical cancer and includes separate guidance for people whose cervix was removed.
Bone density screening is a different kind of test. The Task Force describes dual-energy X-ray absorptiometry, usually abbreviated DXA, as a measure of bone mineral density. The Task Force recommendation applies to adults 40 years or older without known osteoporosis or a prior fragility fracture. It excludes osteoporosis that is secondary to another condition or to certain long-term medication use. Its guidance distinguishes screening based on age from earlier screening after menopause based on an assessment of a person's likelihood of fracture. The page on midlife and menopause covers bone changes after menopause.
| Screening | Who the recommendation covers | How often | Source |
|---|---|---|---|
| Mammography | Women aged 40 to 74 years | Every other year | Task Force breast screening recommendation |
| Cervical screening with a Pap test | Women aged 21 to 29 years | Every 3 years | Task Force cervical screening recommendation |
| Cervical screening with a Pap test, an HPV test or both | Women aged 30 to 65 years | Every 3 years for a Pap test alone, or every 5 years for high-risk HPV testing alone or with a Pap test | Task Force cervical screening recommendation |
| Osteoporosis screening with DXA | Women 65 years or older and postmenopausal women younger than 65 years assessed to have increased fracture risk | The recommendation summary specifies eligibility and the test without a fixed repeat interval. | Task Force osteoporosis screening recommendation |
Human papillomavirus vaccination
The National Cancer Institute describes human papillomavirus, or HPV, as a group of related viruses, some of which can cause cancer. Its fact sheet explains that the HPV vaccine prompts the body to make antibodies against particular kinds of HPV. The fact sheet describes protection against new infections with the types targeted by the vaccine. It distinguishes this purpose from treating an infection that is already present.
The National Cancer Institute reports that the Centers for Disease Control and Prevention routinely recommends vaccination at age 11 or 12, with vaccination possible starting at age 9. The same fact sheet describes catch-up vaccination through age 26 for people who were not adequately vaccinated earlier. For adults ages 27 through 45, the fact sheet describes a discussion with a clinician for some people who were not adequately vaccinated earlier, rather than routine vaccination for everyone in that age group. The Task Force's cervical recommendation applies regardless of HPV vaccination status for the population it covers.
Sources
- Preventive care benefits for women | HealthCare.gov
- Health Checkup: MedlinePlus
- Your First Gynecologic Visit | ACOG
- Cervical Cancer Screening - NCI
- Screening for Breast Cancer - NCI
- The Initial Reproductive Health Visit: ACOG Committee Opinion, Number 811 (2020)
- Recommendation: Breast Cancer: Screening | United States Preventive Services Taskforce
- Recommendation: Cervical Cancer: Screening | United States Preventive Services Taskforce
- Recommendation: Osteoporosis to Prevent Fractures: Screening | United States Preventive Services Taskforce
- Human Papillomavirus (HPV) Vaccine - NCI